UPDATED Feb 19, 2023
Financially strong companies with expected earnings growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
1795Lotus Pharmaceutical | NT$294.50 | 6.1% | 224.0% | NT$77.2b | NT$279.20 | PE24.9x | E32.6% | 0.7% |